Mechanisms of neurohormonal activation in chronic congestive heart failure:: pathophysiology and therapeutic implications

被引:35
作者
Dávila, DF [1 ]
Núñez, TJ [1 ]
Odreman, R [1 ]
de Dávila, CAM [1 ]
机构
[1] Univ Los Andes, Inst Invest Cardiovasc, Merida 5101, Venezuela
关键词
congestive heart failure; sympathetic nervous system; neurohormonal activation; low-pressure cardiac receptors; high-pressure carotid receptors; sympathetic afferents;
D O I
10.1016/j.ijcard.2004.08.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with chronic congestive heart failure have a sequential and incessant activation of those neurohormonal systems, which control body fluids, cardiac output and systemic blood pressure. Neurohormonal activation is initially selective and regional. Generalized activation is a late event in the natural history of congestive heart failure. Although the ultimate stimulus responsible for the activation of these neurohormonal systems is unknown, a decreased cardiac output and diminished effective blood volume have been proposed as the responsible mechanisms. However, extensive clinical and experimental research suggest that cardiac remodeling and loading of low-pressure cardiac receptors with sympathetic afferents could be the triggering events followed by unloading of high-pressure carotid receptors by decreased cardiac output and diminished effective blood volume. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:343 / 346
页数:4
相关论文
共 58 条
[1]  
Aviado DM, 2001, ANN NY ACAD SCI, V940, P48
[2]   Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure [J].
Azevedo, ER ;
Newton, GE ;
Floras, JS ;
Parker, JD .
CIRCULATION, 2000, 101 (17) :2053-2059
[3]   Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction [J].
Benedict, CR ;
Shelton, B ;
Johnstone, DE ;
Francis, G ;
Greenberg, B ;
Konstam, M ;
Probstfield, JL ;
Yusuf, S .
CIRCULATION, 1996, 94 (04) :690-697
[4]  
Choo Daniel C., 2003, Journal of Cardiovascular Pharmacology and Therapeutics, V8, P187, DOI 10.1177/107424840300800303
[5]  
COLUCCI WS, 2001, HEART DIS TXB CARDIO
[6]   Opposite effects of iv amiodarone on cardiovascular vagal and sympathetic efferent activities in rats [J].
Da Silva, VJD ;
Gnecchi-Ruscone, T ;
Lavelli, B ;
Bellina, V ;
Manzella, D ;
Porta, A ;
Malliani, A ;
Montano, N .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2002, 283 (02) :R543-R548
[7]   Plasma norepinephrine, myocardial damage and left ventricular systolic function in Chagas' heart disease [J].
Davila, DF ;
Bellabarba, G ;
Hernandez, L ;
Calmon, G ;
Torres, A ;
Donis, JH ;
Barboza, JS ;
Lemorvan, C ;
Gonzalez, JG .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1995, 52 (02) :145-151
[8]   Cardiac afferents and neurohormonal activation in congestive heart failure [J].
Davila, DF ;
Donis, JH ;
Bellabarba, G ;
Torres, A ;
Casado, J ;
de Davila, CM .
MEDICAL HYPOTHESES, 2000, 54 (02) :242-253
[9]   Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure [J].
DibnerDunlap, ME ;
Smith, ML ;
Kinugawa, T ;
Thames, MD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (02) :358-364
[10]   Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation [J].
Dorian, P ;
Cass, D ;
Schwartz, B ;
Cooper, R ;
Gelaznikas, R ;
Barr, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) :884-890